Vaccine

GSK's thirst for adjuvants grows

GSK's thirst for adjuvants grows

By Gregory Roumeliotis

GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...

Wyeth phases out NY facility

Wyeth phases out NY facility

By Wai Lang Chu

Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All